Loading video...

Video Failed to Load

Go Home

WHAT IF A SINGLE FREQUENCY COULD DESTROY DISEASE AND CRUSH YOUR CELLS FROM WITHIN⁉️🚨🔥 After 15 months of relentless trials, Scientists unlocked a frequency SO POWERFUL it SHATTERS CANCER CELLS LIKE GLASS! This is no ordinary vibration – it's the ELEVENTH HARMONIC! A force that obliterates leukemia cells in...

494,687 views • 1 year ago •via X (Twitter)

11 Comments

ElephantintheRoom's profile picture
ElephantintheRoom1 year ago

Dr Royal Rife

Peptide Sciences's profile picture
Peptide Sciences1 year ago

Discover the research potential of peptides with our FREE eBook! 🧬 Featuring 99% purity, HPLC & Mass Spec tested, with NO TFA, fillers, or binding agents. 🚚 Express shipping available! Trust Peptide Sciences™—your source for 14 years. Click 'Learn More' now!

OracleofTheMatrix's profile picture
OracleofTheMatrix1 year ago

I wrote Dr. Holland when I first got diagnosed with cancer because me background in EE is RF engineering and wave propagation. He responded to me with the best letter you can imagine. He shared all of his knowledge about his studies and everything he knew about alternative cancer treatments! I fully support him! 64Hz X 11 works great for me!

GlostaCrumudgeon's profile picture
GlostaCrumudgeon1 year ago

They’re hijacking Dr Rife’s discovery without crediting him

OracleofTheMatrix's profile picture
OracleofTheMatrix1 year ago

I've been in a real medbed btw! 😎

LR B AK Girl's profile picture
LR B AK Girl1 year ago

❤️

Anna Schaubhut's profile picture
Anna Schaubhut1 year ago

Now we are talking!

Duda's profile picture
Duda1 year ago

So much better than RNA vacines

JL's profile picture
JL1 year ago

Ok with this, what is that new personalized vax about?

Bob's profile picture
Bob1 year ago

🙏

SnowedN47's profile picture
SnowedN471 year ago

That would be incredible! Like music?

Related Videos

🚨Here's what a lot of people misunderstand about cancer treatment, says drpaulmarik: "Cancer is not homogeneous. The somatic mutation theory—which is the current theory in which treatment is based—posits that you have a mutation in a single cell, and that gives rise to a whole population of cells that look the same and have the same mutation. But the Cancer Genome Atlas has shown that that theory is completely wrong. The cancer cells are very heterogeneous, so they're made up of very different populations of cells with different mutations, and one of the populations is the cancer stem cell. It's a sub-population of the cancer. These are generally slow-growing, but they're distinct in that they have the ability to divide indefinitely and grow indefinitely, and can change their characteristics. Basically, if you get rid of the fast-dividing cells, which is the cancer, you're left with the stem cells, which then become the roots, which grow back to form the tumor" sometimes years later. Conventional chemotherapy gets rid of the fast-dividing regular cancer cells but *NOT* the stem cells. So the key question is: how do you get rid of the stem cells? “There are a number of repurposed drugs that do it, and this has been well-established in scientific medical literature. One of the most effective treatments to knock out the stem cell is the famous horse deworming medicine," says drpaulmarik. Yes, ivermectin. Independent Medical Alliance

Jan Jekielek

96,002 views • 1 year ago

🚨ImmunityBio’s Anktiva: A New FDA-Approved Immunotherapy for certain bladder cancer. They are also developing treatments that may reduce the need for strong chemo, for blood cancer, lung cancer, brain cancer, and more. Broader approvals may take time. Someone call the President and fast-track this. Dr. Pat Soon-Shiong leads development beyond typical biotech efforts. Most cancer medicines, like chemotherapy, work by poisoning fast-growing cells to kill the cancer. This also hurts healthy cells, causing side effects like hair loss and weakness. Anktiva is different. It is an immunotherapy that wakes up your body’s own immune cells; natural killer cells and T cells to hunt and destroy cancer cells themselves. It acts like a booster shot for your immune system, using a protein called IL-15 to make these cells multiply and remember how to fight cancer long-term. ImmunityBio is different from most companies because of 3 big unique things: 1. They wake up 3 kinds of fighter cells at the same time: • NK cells (natural killers) • CD8 T cells (main attackers) • CD4 T cells (helpers) These three work together like a basketball team. This makes the body remember the cancer for a long time (maybe years). 2. They have a special cell line called NK-92. → It’s like buying frozen pizza instead of making dough from scratch every time. Doctors can just thaw it and give it to any patient. No need to take cells from the sick kid, customize them, and make them super weak with hospital chemo (that’s what normal CAR-T does). 3. Their medicine Anktiva gives a long, steady boost to the immune cells. Older drugs (like IL-2) gave a short, crazy boost that made people very sick. Anktiva is seems safer, so far. Exciting to follow the development. Interview: Chris Cuomo (NewsNation) — “Killing Cancer”

Black Panther Capital

40,249 views • 7 months ago

Cancer - Chemotherapy wipes out the cells that "protect your body from cancer" For decades, the fundamental protocol for fighting cancer has been chemotherapy and radiation. But what if this approach inadvertently disarms the body's most powerful weapon against the very disease it seeks to destroy? Dr. Patrick Soon-Shiong explains the profound and simple truth: When a patient undergoes chemotherapy, it systematically wipes out critical components of the immune system. 1. It wipes out red blood cells, causing anemia. We have a drug for that: Epogen. 2. It wipes out neutrophils, which prevent infection. We have a drug for that: Neupogen. 3. But most critically, it decimates the lymphocytes—the NK and T cells. Here lies the devastating irony: The NK and T cells are the only cells in the human body that can recognize and kill cancer. So, within days, the standard of care eliminates the patient's primary defense system. For 35 years, we have treated the side effects of anemia and infection, all while having no therapy to restore the very cells that matter most. Dr. Soon-Shiong’s two-decade fight has been to illuminate this paradigm. We have been unintentionally protecting the patient from the consequences of our own treatments while undermining their innate ability to survive. This principle extends beyond oncology. In Long COVID, a similar pattern emerges—a viral infection that cleverly disables the T and NK cells. The lesson is clear: The future of medicine lies not in breaking the body down, but in strategically rebuilding and empowering its innate intelligence. It’s a call to move beyond managing collateral damage and to start fortifying the core of our biological defenses.

Camus

61,712 views • 11 months ago

Dr. Patrick Soon-Shiong presents a fundamental paradigm shift in the war on cancer: we must stop destroying the immune system to save the body, and start supercharging it to achieve a permanent cure. The critical flaw of conventional chemotherapy and radiation is their inadvertent destruction of the very immune cells—the lymphocytes—designed to protect us. This often wins a battle but loses the war, leading to metastasis. The solution lies within us. Dr. Soon-Shiong’s work harnesses "God's design": the power of Natural Killer (NK) cells and T-cells. The breakthrough is two-fold: 1. The Activation Key: For the first time, we can effectively activate these cells using a sustained-release form of IL-15, a natural protein. A single injection can create a tenfold increase in the body's innate cancer-killing army. 2. The Army Expansion: We can now draw a patient's blood, grow billions of targeted NK cells in a lab, and reinfuse them, creating a supercharged, augmented immune response. This is not an incremental improvement. It is a move away from the failed strategy of attacking cancer from the inside-out—blocking internal pathways that cancer easily bypasses—to shattering it from the outside-in. The result is data that speaks to a potential cure: patients with metastatic pancreatic cancer alive and disease-free after five years; bladder cancer patients thriving with their organs intact a decade after treatment; long-term remission in aggressive Merkel cell carcinoma. This approach teaches the immune system "T-cell memory," creating a permanent, living surveillance system that stands guard against recurrence. This is the path to long-term survival with quality of life.

Camus

103,022 views • 11 months ago